These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25241269)

  • 21. The impact of comorbid [corrected] conditions on critical illness.
    Esper AM; Martin GS
    Crit Care Med; 2011 Dec; 39(12):2728-35. PubMed ID: 22094497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma pharmacokinetics of antimicrobial agents in critically ill patients.
    Pea F
    Curr Clin Pharmacol; 2013 Feb; 8(1):5-12. PubMed ID: 22946868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Daptomycin for the treatment of Gram-positive microorganisms in the critically-ill patient].
    Alvarez-Lerma F; Gracia-Arnillas MP
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():29-35. PubMed ID: 21477702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What's new in antimicrobial use and resistance in critically ill patients?
    Bassetti M; Nicolau DP; Calandra T
    Intensive Care Med; 2014 Mar; 40(3):422-6. PubMed ID: 24346656
    [No Abstract]   [Full Text] [Related]  

  • 25. Biomarkers in the critically ill patient: procalcitonin.
    Reinhart K; Meisner M
    Crit Care Clin; 2011 Apr; 27(2):253-63. PubMed ID: 21440200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
    Heintz BH; Matzke GR; Dager WE
    Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial use in a critical care unit: a prospective observational study.
    Candeloro CL; Kelly LM; Bohdanowicz E; Martin CM; Bombassaro AM
    Int J Pharm Pract; 2012 Jun; 20(3):164-71. PubMed ID: 22554159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring antimicrobial prescribing quality in Australian hospitals: development and evaluation of a national antimicrobial prescribing survey tool.
    James R; Upjohn L; Cotta M; Luu S; Marshall C; Buising K; Thursky K
    J Antimicrob Chemother; 2015; 70(6):1912-8. PubMed ID: 25724986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
    Álvarez-Lerma F; Palomar Martínez M; Olaechea Astigarraga P; Insausti Ordeñana J; López Pueyo MJ; Gracia Arnillas MP; Gimeno Costa R; Seijas Betolaza I
    Rev Esp Quimioter; 2012 Mar; 25(1):65-73. PubMed ID: 22488544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypomagnesemia in critically ill medical patients.
    Limaye CS; Londhey VA; Nadkart MY; Borges NE
    J Assoc Physicians India; 2011 Jan; 59():19-22. PubMed ID: 21751660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Surveillance of antimicrobial drug use in Mexican hospitals: current situation and practical guidelines for its implementation].
    Rodríguez-Ganen O; Asbun-Bojalil J
    Rev Panam Salud Publica; 2012 Nov; 32(5):381-6. PubMed ID: 23338696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What can be expected from antimicrobial de-escalation in the critically ill?
    Kollef MH
    Intensive Care Med; 2014 Jan; 40(1):92-5. PubMed ID: 24248604
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term outcome of critically ill elderly patients requiring intensive care.
    Chelluri L; Pinsky MR; Donahoe MP; Grenvik A
    JAMA; 1993 Jun 23-30; 269(24):3119-23. PubMed ID: 8505814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial stewardship of β-lactams in intensive care units.
    Cotta MO; Roberts JA; Tabah A; Lipman J; Vogelaers D; Blot S
    Expert Rev Anti Infect Ther; 2014 May; 12(5):581-95. PubMed ID: 24655303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibiotic policy in critical patients].
    Alvarez Lerma F; Sierra Camerino R; Alvarez Rocha L; Rodríguez Colomo O
    Med Intensiva; 2010 Dec; 34(9):600-8. PubMed ID: 20466458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus recommendations for the management of hyperglycaemia in critically ill patients in the Indian setting.
    Mukherjee JJ; Chatterjee PS; Saikia M; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):16-25. PubMed ID: 25668933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibiotics in the critically ill].
    Kolak RR
    Med Pregl; 2010; 63 Suppl 1():27-32. PubMed ID: 21438201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective audit for antimicrobial stewardship in intensive care: impact on resistance and clinical outcomes.
    DiazGranados CA
    Am J Infect Control; 2012 Aug; 40(6):526-9. PubMed ID: 21937145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neurological manifestations in critically ill patients].
    López-Rodríguez L; Hidalgo-Alquicira FG; Mimenza-Alvarado AJ
    Rev Neurol; 2006 Aug 1-15; 43(3):155-67. PubMed ID: 16871481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients' transition in the intensive care units: concept analysis.
    Ludin SM; Arbon P; Parker S
    Intensive Crit Care Nurs; 2013 Aug; 29(4):187-92. PubMed ID: 23727138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.